P
22.95
-0.06 (-0.26%)
| Previous Close | 23.01 |
| Open | 22.99 |
| Volume | 74,427 |
| Avg. Volume (3M) | 816,663 |
| Market Cap | 2,798,064,128 |
| Price / Earnings (TTM) | 191.25 |
| Price / Earnings (Forward) | 42.02 |
| Price / Sales | 1.54 |
| Price / Book | 4.07 |
| 52 Weeks Range | |
| Earnings Date | 6 Aug 2025 - 11 Aug 2025 |
| Profit Margin | 0.87% |
| Operating Margin (TTM) | 1.09% |
| Diluted EPS (TTM) | 0.120 |
| Quarterly Revenue Growth (YOY) | 15.60% |
| Quarterly Earnings Growth (YOY) | 41.40% |
| Total Debt/Equity (MRQ) | 0.77% |
| Current Ratio (MRQ) | 1.88 |
| Operating Cash Flow (TTM) | 118.36 M |
| Levered Free Cash Flow (TTM) | 110.63 M |
| Return on Assets (TTM) | 1.21% |
| Return on Equity (TTM) | 3.01% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Bearish | Mixed |
| Health Information Services (Global) | Bearish | Mixed | |
| Stock | Privia Health Group, Inc. | Bearish | Bullish |
AIStockmoo Score
0.8
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | -1.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -0.5 |
| Average | 0.75 |
|
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Growth |
| % Held by Insiders | 6.71% |
| % Held by Institutions | 100.20% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Rubicon Founders Llc | 31 Mar 2025 | 5,773,522 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 32.00 (JP Morgan, 39.43%) | Buy |
| Median | 28.50 (24.18%) | |
| Low | 24.00 (Barclays, 4.58%) | Hold |
| Average | 28.17 (22.75%) | |
| Total | 5 Buy, 1 Hold | |
| Avg. Price @ Call | 23.51 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| JP Morgan | 28 May 2025 | 32.00 (39.43%) | Buy | 23.07 |
| Barclays | 27 May 2025 | 24.00 (4.58%) | Hold | 23.32 |
| 10 Apr 2025 | 23.00 (0.22%) | Hold | 23.65 | |
| JMP Securities | 28 Apr 2025 | 29.00 (26.36%) | Buy | 23.20 |
| Baird | 15 Apr 2025 | 26.00 (13.29%) | Buy | 24.19 |
| Needham | 10 Apr 2025 | 30.00 (30.72%) | Buy | 23.65 |
| Truist Securities | 10 Apr 2025 | 28.00 (22.00%) | Buy | 23.65 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 08 May 2025 | Announcement | Privia Health Reports First Quarter 2025 Financial Results |
| 09 Apr 2025 | Announcement | Privia Health Enters Arizona In Partnership with Integrated Medical Services |
| 08 Apr 2025 | Announcement | Privia Health to Report First Quarter 2025 Results on Thursday, May 8 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |